 | DMT | Name: | 3-HYDROXY-4,4-DIMETHYL-2-(METHYLAMINO)-6-OCTENOIC ACID | Formula: | C11 H21 N O3 | SMILES: | O=C(O)C(NC)C(O)C(C/C=C/C)(C)C | InChi: | InChI=1S/C11H21NO3/c1-5-6-7-11(2,3)9(13)8(12-4)10(14)15/h5-6,8-9,12-13H,7H2,1-4H3,(H,14,15)/b6-5+/t8-,9-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 4-[(2E)-but-2-en-1-yl]-2,4,5-trideoxy-4-methyl-2-(methylamino)-D-arabinonic acid |
|
 | DN1 | Name: | 3-({(2S)-2-[({(1R)-1-[({(1R)-1-[(R)-CARBOXY(HYDROXY)METHYL]-3,3-DIFLUOROPROPYL}AMINO)CARBONYL]-3-METHYLBUTYL}AMINO)CARB
ONYL]-2,3-DIHYDRO-1H-INDOL-2-YL}METHYL)THIOPHENE-2-CARBOXYLIC ACID | Formula: | C26 H31 F2 N3 O7 S | SMILES: | O=C(O)C(O)C(NC(=O)C(NC(=O)C2(Nc1ccccc1C2)Cc3c(scc3)C(=O)O)CC(C)C)CC(F)F | InChi: | InChI=1S/C26H31F2N3O7S/c1-13(2)9-18(22(33)29-17(10-19(27)28)20(32)23(34)35)30-25(38)26(11-14-5-3-4-6-16(14)31-26)12-15-7-8-39-21(15)24(36)37/h3-8,13,17-20,31-32H,9-12H2,1-2H3,(H,29,33)(H,30,38)(H,34,35)(H,36,37)/t17-,18-,20-,26+/m1/s1 | Synonyms: | PEPTIDOMIMETIC INHIBITOR | Definition date: | 2004-07-14 | Last modified: | 2024-09-27 | Identifier: | 3-{[N-({(2S)-2-[(2-carboxythiophen-3-yl)methyl]-2,3-dihydro-1H-indol-2-yl}carbonyl)-D-leucyl]amino}-3,4,5-trideoxy-5,5-difluoro-D-erythro-pentonic acid |
|
 | DNE | Name: | D-NORLEUCINE | Formula: | C6 H13 N O2 | SMILES: | O=C(O)C(N)CCCC | InChi: | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m1/s1 | Definition date: | 2003-11-14 | Last modified: | 2024-09-27 | Identifier: | D-norleucine |
|
 | DNG | Name: | N-FORMYL-D-NORLEUCINE | Formula: | C7 H13 N O3 | SMILES: | O=CNC(C(=O)O)CCCC | InChi: | InChI=1S/C7H13NO3/c1-2-3-4-6(7(10)11)8-5-9/h5-6H,2-4H2,1H3,(H,8,9)(H,10,11)/t6-/m1/s1 | Definition date: | 2004-01-27 | Last modified: | 2024-09-27 | Identifier: | N-formyl-D-norleucine |
|
 | DNM | Name: | N-methyl-D-norleucine | Formula: | C7 H15 N O2 | SMILES: | C(C(NC)CCCC)(=O)O | InChi: | InChI=1S/C7H15NO2/c1-3-4-5-6(8-2)7(9)10/h6,8H,3-5H2,1-2H3,(H,9,10)/t6-/m1/s1 | Definition date: | 2003-11-17 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-norleucine |
|
 | DP7 | Name: | AC-(D)PHE-PRO-BOROARG-OH | Formula: | C21 H33 B N6 O5 | SMILES: | O=C(NC(B(O)O)CCCNC(=[N@H])N)C2N(C(=O)C(NC(=O)C)Cc1ccccc1)CCC2 | InChi: | InChI=1S/C21H33BN6O5/c1-14(29)26-16(13-15-7-3-2-4-8-15)20(31)28-12-6-9-17(28)19(30)27-18(22(32)33)10-5-11-25-21(23)24/h2-4,7-8,16-18,32-33H,5-6,9-13H2,1H3,(H,26,29)(H,27,30)(H4,23,24,25)/t16-,17+,18+/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-acetyl-D-phenylalanyl-N-[(1R)-4-carbamimidamido-1-(dihydroxyboranyl)butyl]-L-prolinamide |
|
 | Y1Y | Name: | 3-amino-2,3-dideoxy-5-O-(5-methylthiophene-2-carbonyl)-D-erythro-pentonic acid | Formula: | C11 H15 N O5 S | SMILES: | Cc1sc(cc1)C(=O)OCC(C(N)CC(O)=O)O | InChi: | InChI=1S/C11H15NO5S/c1-6-2-3-9(18-6)11(16)17-5-8(13)7(12)4-10(14)15/h2-3,7-8,13H,4-5,12H2,1H3,(H,14,15)/t7-,8+/m0/s1 | Definition date: | 2020-06-02 | Last modified: | 2024-09-27 | Release date: | 2021-06-02 | Identifier: | 3-amino-2,3-dideoxy-5-O-(5-methylthiophene-2-carbonyl)-D-erythro-pentonic acid |
|
 | DPN | Name: | D-PHENYLALANINE | Formula: | C9 H11 N O2 | SMILES: | O=C(O)C(N)Cc1ccccc1 | InChi: | InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | D-phenylalanine |
|
 | DRZ | Name: | 3',4'-DIHYDROXY-PENTANAL-5'-PHOSPHATE | Formula: | C5 H11 O7 P | SMILES: | O=P(O)(O)OCC(O)C(O)CC=O | InChi: | InChI=1S/C5H11O7P/c6-2-1-4(7)5(8)3-12-13(9,10)11/h2,4-5,7-8H,1,3H2,(H2,9,10,11)/t4-,5+/m0/s1 | Definition date: | 2002-07-18 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-5-O-phosphono-D-erythro-pentose |
|
 | DSE | Name: | N-METHYL-D-SERINE | Formula: | C4 H9 N O3 | SMILES: | O=C(O)C(NC)CO | InChi: | InChI=1S/C4H9NO3/c1-5-3(2-6)4(7)8/h3,5-6H,2H2,1H3,(H,7,8)/t3-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-serine |
|
 | 5JR | Name: | N-[2-[[3-(3,5-dimethoxyphenyl)-2-oxidanylidene-1-[3-(4-propanoylpiperazin-1-yl)propyl]-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]phenyl]propanamide | Formula: | C33 H42 N8 O5 | SMILES: | CCC(=O)Nc1ccccc1Nc2ncc3CN(C(=O)N(CCCN4CCN(CC4)C(=O)CC)c3n2)c5cc(OC)cc(OC)c5 | InChi: | InChI=1S/C33H42N8O5/c1-5-29(42)35-27-10-7-8-11-28(27)36-32-34-21-23-22-41(24-18-25(45-3)20-26(19-24)46-4)33(44)40(31(23)37-32)13-9-12-38-14-16-39(17-15-38)30(43)6-2/h7-8,10-11,18-21H,5-6,9,12-17,22H2,1-4H3,(H,35,42)(H,34,36,37) | Definition date: | 2021-08-19 | Last modified: | 2024-09-27 | Release date: | 2022-03-30 | Identifier: | ~{N}-[2-[[3-(3,5-dimethoxyphenyl)-2-oxidanylidene-1-[3-(4-propanoylpiperazin-1-yl)propyl]-4~{H}-pyrimido[4,5-d]pyrimidin-7-yl]amino]phenyl]propanamide |
|
 | 5PL | Name: | (1R,4S,6R)-6-({[2-(ACETYLAMINO)-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL]OXY}METHYL)-4-HYDROXY-1-{[(15-METHYLHEXADECANOYL)OXY]METHYL}-4-OXIDO-7-OXO-3,5-DIOXA-8-AZA-4-PHOSPHAHEPTACOS-1-YL 15-METHYLHEXADECANOATE | Formula: | C67 H129 N2 O15 P | SMILES: | O=C(OCC(OC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC(C(=O)NCCCCCCCCCCCCCCCCCCC)COC1OC(C(O)C(O)C1NC(=O)C)CO)CCCCCCCCCCCCCC(C)C | InChi: | InChI=1S/C67H129N2O15P/c1-7-8-9-10-11-12-13-14-15-16-17-18-25-30-35-40-45-50-68-66(76)60(54-80-67-63(69-57(6)71)65(75)64(74)59(51-70)83-67)84-85(77,78)81-53-58(82-62(73)49-44-39-34-29-24-20-22-27-32-37-42-47-56(4)5)52-79-61(72)48-43-38-33-28-23-19-21-26-31-36-41-46-55(2)3/h55-56,58-60,63-65,67,70,74-75H,7-54H2,1-6H3,(H,68,76)(H,69,71)(H,77,78)/t58-,59-,60-,63-,64-,65-,67+/m1/s1 | Definition date: | 2011-03-31 | Last modified: | 2024-09-27 | Identifier: | (1R,4S,6R)-6-({[2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl]oxy}methyl)-4-hydroxy-1-{[(15-methylhexadecanoyl)oxy]methyl}-4-oxido-7-oxo-3,5-dioxa-8-aza-4-phosphaheptacos-1-yl 15-methylhexadecanoate |
|
 | 5QP | Name: | (1R,2R,3S,5R,6S)-2,3,5-trihydroxy-6-(hydroxymethyl)cyclohexyl alpha-D-glucopyranoside | Formula: | C13 H24 O10 | SMILES: | OC[CH]1O[CH](O[CH]2[CH](O)[CH](O)C[CH](O)[CH]2CO)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C13H24O10/c14-2-4-5(16)1-6(17)8(18)12(4)23-13-11(21)10(20)9(19)7(3-15)22-13/h4-21H,1-3H2/t4-,5+,6-,7+,8+,9+,10-,11+,12+,13+/m0/s1 | Synonyms: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(1~{R},2~{S},3~{R},5~{S},6~{R})-2-(hydroxymethyl)-3,5,6-tris(oxida
nyl)cyclohexyl]oxy-oxane-3,4,5-triol | Definition date: | 2015-11-10 | Last modified: | 2024-09-27 | Release date: | 2016-07-06 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(1~{R},2~{S},3~{R},5~{S},6~{R})-2-(hydroxymethyl)-3,5,6-tris(oxida
nyl)cyclohexyl]oxy-oxane-3,4,5-triol |
|
 | 5RP | Name: | RIBULOSE-5-PHOSPHATE | Formula: | C5 H11 O8 P | SMILES: | O=P(O)(O)OCC(O)C(O)C(=O)CO | InChi: | InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/t4-,5+/m1/s1 | Definition date: | 2004-07-09 | Last modified: | 2024-09-27 | Identifier: | 5-O-phosphono-D-ribulose |
|
 | DT6 | Name: | 2,4-bisacetamido-2,4-dideoxy-beta-D-glucopyranose | Formula: | C10 H18 N2 O6 | SMILES: | O=C(NC1C(OC(O)C(NC(=O)C)C1O)CO)C | InChi: | InChI=1S/C10H18N2O6/c1-4(14)11-7-6(3-13)18-10(17)8(9(7)16)12-5(2)15/h6-10,13,16-17H,3H2,1-2H3,(H,11,14)(H,12,15)/t6-,7-,8-,9+,10-/m1/s1 | Synonyms: | 2,4-bis(acetylamino)-2,4-dideoxy-beta-D-glucopyranose | Definition date: | 2006-06-29 | Last modified: | 2024-09-27 | Identifier: | 2,4-bis(acetylamino)-2,4-dideoxy-beta-D-glucopyranose |
|
 | DWI | Name: | (2~{S})-1-[4-[7-(8-ethynyl-7-fluoranyl-naphthalen-1-yl)-8-fluoranyl-2-[[(2~{R},8~{S})-2-fluoranyl-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl]-2-oxidanyl-propan-1-one | Formula: | C34 H33 F3 N6 O3 | SMILES: | C[CH](O)C(=O)N1CCN(CC1)c2nc(OC[C]34CCCN3C[CH](F)C4)nc5c(F)c(ncc25)c6cccc7ccc(F)c(C#C)c67 | InChi: | InChI=1S/C34H33F3N6O3/c1-3-23-26(36)9-8-21-6-4-7-24(27(21)23)29-28(37)30-25(17-38-29)31(41-12-14-42(15-13-41)32(45)20(2)44)40-33(39-30)46-19-34-10-5-11-43(34)18-22(35)16-34/h1,4,6-9,17,20,22,44H,5,10-16,18-19H2,2H3/t20-,22+,34-/m0/s1 | Definition date: | 2023-06-06 | Last modified: | 2024-09-27 | Release date: | 2024-01-31 | Identifier: | (2~{S})-1-[4-[7-(8-ethynyl-7-fluoranyl-naphthalen-1-yl)-8-fluoranyl-2-[[(2~{R},8~{S})-2-fluoranyl-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl]-2-oxidanyl-propan-1-one |
|
 | E03 | Name: | 6-FLUORO-D-TRYPTOPHAN | Formula: | C11 H11 F N2 O2 | SMILES: | N[CH](Cc1c[nH]c2cc(F)ccc12)C(O)=O | InChi: | InChI=1S/C11H11FN2O2/c12-7-1-2-8-6(3-9(13)11(15)16)5-14-10(8)4-7/h1-2,4-5,9,14H,3,13H2,(H,15,16)/t9-/m1/s1 | Synonyms: | (2R)-2-azanyl-3-(6-fluoranyl-1H-indol-3-yl)propanoic acid | Definition date: | 2019-09-27 | Last modified: | 2024-09-27 | Release date: | 2019-10-16 | Identifier: | (2~{R})-2-azanyl-3-(6-fluoranyl-1~{H}-indol-3-yl)propanoic acid |
|
 | E47 | Name: | 5-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-oxidanyl-benzaldehyde | Formula: | C17 H16 N4 O3 | SMILES: | Oc1ccc(cc1C=O)c2c[nH]c3ncnc(N4CCOCC4)c23 | InChi: | InChI=1S/C17H16N4O3/c22-9-12-7-11(1-2-14(12)23)13-8-18-16-15(13)17(20-10-19-16)21-3-5-24-6-4-21/h1-2,7-10,23H,3-6H2,(H,18,19,20) | Definition date: | 2023-06-13 | Last modified: | 2024-09-27 | Release date: | 2023-10-18 | Identifier: | 5-(4-morpholin-4-yl-7~{H}-pyrrolo[2,3-d]pyrimidin-5-yl)-2-oxidanyl-benzaldehyde |
|
 | 4C9 | Name: | (2S)-2-({(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}carbonyl)-4,4-dimethylpentanenitrile | Formula: | C30 H33 N7 O2 | SMILES: | N#CC(C(=O)N5CCCC(n2nc(c1c(ncnc12)N)c4ccc(Oc3ccccc3)cc4)C5)CC(C)(C)C | InChi: | InChI=1S/C30H33N7O2/c1-30(2,3)16-21(17-31)29(38)36-15-7-8-22(18-36)37-28-25(27(32)33-19-34-28)26(35-37)20-11-13-24(14-12-20)39-23-9-5-4-6-10-23/h4-6,9-14,19,21-22H,7-8,15-16,18H2,1-3H3,(H2,32,33,34)/t21-,22-/m1/s1 | Definition date: | 2015-02-27 | Last modified: | 2024-09-27 | Release date: | 2015-05-13 | Identifier: | (2S)-2-({(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}carbonyl)-4,4-dimethylpentanenitrile |
|
 | 4EY | Name: | 3-methanethioyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium | Formula: | C12 H15 N O8 P S2 | SMILES: | O=C(S)c1cc(c[n+](c1)C1OC(COP(=O)(O)O)C(O)C1O)C=S | InChi: | InChI=1S/C12H14NO8PS2/c14-9-8(4-20-22(17,18)19)21-11(10(9)15)13-2-6(5-23)1-7(3-13)12(16)24/h1-3,5,8-11,14-15H,4H2,(H2-,16,17,18,19,24)/p+1/t8-,9-,10-,11-/m1/s1 | Synonyms: | Dithiodinicotinic acid mononucleotide | Definition date: | 2015-03-13 | Last modified: | 2024-09-27 | Release date: | 2015-07-15 | Identifier: | 3-methanethioyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium |
|
 | 4N3 | Name: | N-octanoyl-D-valine | Formula: | C13 H25 N O3 | SMILES: | N(C(C(C)C)C(=O)O)C(=O)CCCCCCC | InChi: | InChI=1S/C13H25NO3/c1-4-5-6-7-8-9-11(15)14-12(10(2)3)13(16)17/h10,12H,4-9H2,1-3H3,(H,14,15)(H,16,17)/t12-/m1/s1 | Definition date: | 2016-05-23 | Last modified: | 2024-09-27 | Release date: | 2016-09-28 | Identifier: | N-octanoyl-D-valine |
|
 | EBQ | Name: | (3S)-3-hydroxybutyl alpha-D-glucopyranoside | Formula: | C10 H20 O7 | SMILES: | C[CH](O)CCO[CH]1O[CH](CO)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C10H20O7/c1-5(12)2-3-16-10-9(15)8(14)7(13)6(4-11)17-10/h5-15H,2-4H2,1H3/t5-,6+,7+,8-,9+,10-/m0/s1 | Synonyms: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(3~{S})-3-oxidanylbutoxy]oxane-3,4,5-triol | Definition date: | 2010-06-04 | Last modified: | 2024-09-27 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-6-[(3~{S})-3-oxidanylbutoxy]oxane-3,4,5-triol |
|
 | EEN | Name: | 2-deoxy-2-[(difluoroacetyl)amino]-alpha-D-galactopyranose | Formula: | C8 H13 F2 N O6 | SMILES: | OC[CH]1O[CH](O)[CH](NC(=O)C(F)F)[CH](O)[CH]1O | InChi: | InChI=1S/C8H13F2NO6/c9-6(10)7(15)11-3-5(14)4(13)2(1-12)17-8(3)16/h2-6,8,12-14,16H,1H2,(H,11,15)/t2-,3-,4+,5-,8+/m1/s1 | Synonyms: | N-DIFLUOROACETYL-D-GALACTOSAMINE | Definition date: | 2018-03-16 | Last modified: | 2024-09-27 | Release date: | 2019-02-20 | Identifier: | 2,2-bis(fluoranyl)-~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]ethanamide |
|
 | EEQ | Name: | 2-deoxy-2-[(fluoroacetyl)amino]-alpha-D-galactopyranose | Formula: | C8 H14 F N O6 | SMILES: | OC[CH]1O[CH](O)[CH](NC(=O)CF)[CH](O)[CH]1O | InChi: | InChI=1S/C8H14FNO6/c9-1-4(12)10-5-7(14)6(13)3(2-11)16-8(5)15/h3,5-8,11,13-15H,1-2H2,(H,10,12)/t3-,5-,6+,7-,8+/m1/s1 | Synonyms: | 2-fluoranyl-~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]ethanamide | Definition date: | 2018-03-16 | Last modified: | 2024-09-27 | Release date: | 2019-02-20 | Identifier: | 2-fluoranyl-~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]ethanamide |
|
 | END | Name: | 1,6:5,9:8,12:11,16-TETRAANHYDRO-2,3,4,10,13,14-HEXADEOXY-D-GLYCERO-D-ALLO-D-GULO-HEPTADECA-2,13-DIENITOL | Formula: | C17 H24 O7 | SMILES: | O2C(C(O)C=CC3OC1C(O)C4OCC=CCC4OC1CC23)CO | InChi: | InChI=1S/C17H24O7/c18-8-14-9(19)4-5-10-12(23-14)7-13-17(24-10)15(20)16-11(22-13)3-1-2-6-21-16/h1-2,4-5,9-20H,3,6-8H2/t9-,10+,11-,12-,13+,14+,15+,16-,17+/m0/s1 | Definition date: | 2007-10-03 | Last modified: | 2024-09-27 | Identifier: | 1,6:5,9:8,12:11,16-tetraanhydro-2,3,4,10,13,14-hexadeoxy-D-glycero-D-allo-D-gulo-heptadeca-2,13-dienitol |
|